Priming Activity of Adult and Newborn Plasma
| Expt. No. . | Adult . | Newborn (NB, 10%) . | Adult . | Newborn (8%) . | AD + NB (2% + 8%) . |
|---|---|---|---|---|---|
| . | (AD, 10%) . | . | (2%) . | . | . |
| 1 | 3.7* | 2.8 | 2.3 | 2.4 | 3.3 |
| 2 | 2.5 | 2.3 | 2.0 | 2.0 | 3.0 |
| 3 | 5.5 | 3.8 | 3.5 | 3.8 | 4.5 |
| 4 | 3.6 | 2.0 | 2.0 | 2.1 | 2.6 |
| Mean ± SE | 4.08 ± 0.45 | 2.73 ± 0.4 | 2.45 ± 0.35 | 2.58 ± 0.4 | 3.36 ± 0.4 |
| Expt. No. . | Adult . | Newborn (NB, 10%) . | Adult . | Newborn (8%) . | AD + NB (2% + 8%) . |
|---|---|---|---|---|---|
| . | (AD, 10%) . | . | (2%) . | . | . |
| 1 | 3.7* | 2.8 | 2.3 | 2.4 | 3.3 |
| 2 | 2.5 | 2.3 | 2.0 | 2.0 | 3.0 |
| 3 | 5.5 | 3.8 | 3.5 | 3.8 | 4.5 |
| 4 | 3.6 | 2.0 | 2.0 | 2.1 | 2.6 |
| Mean ± SE | 4.08 ± 0.45 | 2.73 ± 0.4 | 2.45 ± 0.35 | 2.58 ± 0.4 | 3.36 ± 0.4 |
Plasma priming activity was expressed as fold increase (FI) of PMN fMLP-triggered CL activity for samples containing LPS and plasma divided by CL activity for samples containing LPS and HBSS (no plasma).